Exploring the role of interleukin-6 receptor blockade in epilepsy and associated neuropsychiatric conditions through a mendelian randomization study

Figure 3 Correlation between genetically mediated C-reactive protein levels and the risk of epilepsy. A: Forest plot illustrating mendelian randomization (MR) effect estimates and 95% confidence intervals (CI) for the genetically mediated C-reactive protein (CRP) levels' impact on epilepsy; B: Forest plot displaying MR effect estimates and 95%CI for the genetically mediated CRP levels' impact on generalized epilepsy; C: Forest plot displaying MR effect estimates and 95%CI for the genetically mediated CRP levels' impact on focal epilepsy; D: Forest plot displaying MR effect estimates and 95%CI for the genetically mediated CRP levels' impact on juvenile absence epilepsy, childhood absence epilepsy, and juvenile myoclonic epilepsy. SNP: Single nucleotide polymorphism; OR: Odds ratio; CI: Confidence intervals.